Shenyang Sunshine Pharmaceutical

Researchers are testing an experimental antibody called 3SC009 in adults with advanced or metastatic solid tumors that have not responded to other treatments. The drug is a bispecific antibody, meaning it binds to two different targets on cancer cells, CD47 and EpCAM. The trial h…

This phase II trial is testing whether combining an experimental antibody called SSGJ-612 with a targeted chemotherapy (an antibody-drug conjugate) can shrink tumors in people with hormone receptor-positive, HER2-low or HER2-ultralow metastatic breast cancer. The study enrolls ab…

This early-phase trial tests a new biologic drug called SPGL008, given alone or with the standard therapy BCG, in 120 people with high-risk non-muscle-invasive bladder cancer who are not candidates for bladder removal. The main goals are to find a safe dose and see if the drug ca…

This Phase 2 trial will test an experimental drug called SSGJ-706 combined with standard chemotherapy (and sometimes another drug, bevacizumab) in 300 people with advanced gastrointestinal cancers that cannot be surgically removed. The goal is to see if the combination is safe an…

This early-stage trial will test the safety of a single dose of SSS68 in 50 healthy adults aged 18-45. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and how the drug moves through the body. The study is not yet recruiting an…

This is an early-stage study testing a new drug, SSS67, in 52 healthy adults. The main goal is to see if it is safe and how the body handles it. Participants receive a single dose of SSS67 or a placebo by IV. The study also looks at how the drug affects bone markers and metabolis…